|
|
||||||||
From the Department of Neurology (Drs. Xu, Jankovic, Ashizawa, and Le, and C. Hunter) and Department of Cellular and Molecuolar Biology (Dr. Liang), Baylor College of Medicine; Department of Epidemiology (Dr. Zeng), MD Anderson Cancer Center; and Department of Biometry (Dr. Lai), University of Texas, School of Public Health, Houston; and Department of Neurology (Dr. Xu), Sun Yat-Sen University of Medical Sciences, China.
Address correspondence and reprint requests to Dr. Wei-dong Le, Department of Neurology, Baylor College of Medicine, 6501 Fannin Street, Houston, TX 77030; e-mail: Weidongl{at}bcm.tmc.edu
Objective: To determine whether the Nurr1 gene, which is critical for the development and maintenance of nigral dopaminergic neurons, is a risk factor associated with PD.
Background: The Nurrl gene is highly expressed in the dopaminergic neurons in the midbrain. Knockout of the gene results in agenesis of nigral dopaminergic neurons and heterozygous knockout mice increases 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity.
Methods: This study included 105 patients with familial PD (fPD) and 120 patients with sporadic PD (sPD) and 221 age-matched healthy control subjects. The polymorphisms and mutations of the Nurr1 gene in patients with PD were initially examined by heteroduplex analysis and sequencing analysis from PCR-amplified Nurr1 gene fragments. A polymorphism in the BseRI restriction site was identified, and a relatively large-scale analysis then was conducted by three independent investigators who were blinded to the clinical status of the subjects.
Results: A homozygous 7048G7049 polymorphism was found in intron 6 of the Nurr1 gene, which was significantly higher in fPD (10/105; 9.5%) and in sPD (5/120; 4.2%) compared with healthy control subjects (2/221; 0.9%). The mean age and the SD at onset of these homozygote patients with PD was 52 ± 15 years for fPD and 46 ± 7 years for sPD. The clinical features of these homozygote patients with PD did not differ from those of typical PD.
Conclusions: The homozygote polymorphism of 7048G7049 in intron 6 of the Nurr1 gene is associated with typical PD.
This article has been cited by other articles:
![]() |
D. Gherbassi, L. Bhatt, S. Thuret, and H. H. Simon Merging Mouse Transcriptome Analyses with Parkinson's Disease Linkage Studies DNA Res, May 23, 2007; (2007) dsm007v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Colon-Cesario, M. M. Martinez-Montemayor, S. Morales, J. Felix, J. Cruz, M. Adorno, L. Pereira, N. Colon, C. S. Maldonado-Vlaar, and S. Pena de Ortiz Knockdown of Nurr1 in the rat hippocampus: Implications to spatial discrimination learning and memory Learn. Mem., November 1, 2006; 13(6): 734 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ibanez, E. Lohmann, P. Pollak, F. Durif, C. Tranchant, Y. Agid, A. Durr, and A. Brice Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease Neurology, June 8, 2004; 62(11): 2133 - 2134. [Full Text] [PDF] |
||||
![]() |
R. Hering, S. Petrovic, E. -M. Mietz, C. Holzmann, D. Berg, P. Bauer, D. Woitalla, T. Muller, K. Berger, R. Kruger, et al. Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease Neurology, April 13, 2004; 62(7): 1231 - 1232. [Full Text] [PDF] |
||||
![]() |
N. Pankratz, W. C. Nichols, S. K. Uniacke, C. Halter, J. Murrell, A. Rudolph, C. W. Shults, P. M. Conneally, T. Foroud, and the Parkinson Study Group Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families Hum. Mol. Genet., October 16, 2003; 12(20): 2599 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zheng, B. Heydari, and D. K. Simon A Common NURR1 Polymorphism Associated With Parkinson Disease and Diffuse Lewy Body Disease Arch Neurol, May 1, 2003; 60(5): 722 - 725. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |